OPCH Stock Recent News

Option Care Health gives investors exposure to two healthcare megatrends: (i) the shift to healthcare delivery in the home; and (ii) the development of specialty pharmaceuticals. I believe OPCH holds a competitive moat, not only as the largest infusion provider in the US, but also due to its business model (predictable revenue and sticky client/customer base). I explain the street is highly conservative and project a ~150bps upside to FY24E EBITDA, and apply a ~15x multiple to that projection to arrive at my $38 2024 PT.

Analysts are hopeful that holiday shopping news will bode well for the economy after retail sales increased 0.3% in November. This moderate growth for the economy eased economist's outlooks on a looming recession.

Option Care Health easily beat analysts' models for revenue and earnings in the third quarter of 2023. The company also raised its full-year outlook -- but not enough to live up to Wall Street's already high expectations.

Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2023 Earnings Conference Call October 25, 2023 8:30 AM ET Company Participants Mike Shapiro - CFO John Rademacher - CEO Conference Call Participants David MacDonald - Truist Madeline Mollman - William Blair Lisa Gill - JPMorgan Joanna Gajuk - Bank of America Merrill Lynch Brian Tanquilut - Jefferies Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Michael Petusky - Barrington Research Operator Good day, and thank you for standing by. Welcome to the Option Care Health Third Quarter 2023 Earnings Conference Call.

Option Care (OPCH) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.21 per share a year ago.

Option Care Health's (OPCH) Q3 results are likely to be driven by sustained strong utilization.

BANNOCKBURN, Ill., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2023 on Wednesday, October 25, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

AMWD, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 27, 2023.

Option Care (OPCH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

OPCH, NJDCY and AMWD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 12, 2023.